Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Iowa for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Iowa only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Iowa (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Todd Heilskov (NPI 1225098759)

Field	Value
Entity Type	Individual
Organization	Todd Heilskov
Address	1501 50th St
City	West Des Moines
State	IA
ZIP	50266
Taxonomy	Ophthalmology Physician
NPI Enumerated	March 27, 2006

Payer Source	Total Paid
Medicare	$3.8M
Medicaid	$0

Key Findings

This provider is effectively a single-payer Medicare practice: Total Medicare revenue is $3.8M and there is no Medicaid billing on file, so Medicaid is not a material part of this provider’s payer mix. Analysts should treat Medicare as the dominant and only reported public payer when modeling exposure or reimbursement sensitivity.

Revenue is highly concentrated in a small set of drug and injection codes: the precomputed top 3 Medicare codes by revenue account for 87.9% of total Medicare revenue, driven by J2777 (49.1% of Medicare revenue, $1.9M), J0178 (32.2% of Medicare revenue, $1.2M), and 67028 (6.7% of Medicare revenue, $255K). This concentration indicates the bulk of billings and cash flow are tied to intravitreal biologic therapy and the associated injection procedure.

The code mix and top revenue lines indicate a clinical focus on medical retina and intravitreal therapy: J2777 (faricimab) and J0178 (aflibercept) are the two largest revenue drivers and 67028 is the procedure code for intravitreal injection, while 92134 (retinal imaging) appears among the top codes with $111K in revenue. Together this pattern is consistent with a high-volume retina injection clinic that couples diagnostic imaging with frequent therapeutic injections.

For several retina-related codes this provider ranks well above peers nationally: J2777 ranks #61 of 2039 providers (97th percentile) and is described as notably above typical national volume, 67028 ranks #108 of 4255 providers (97th percentile) and is also notably above typical national volume, while J0178 sits at the 80th percentile (#651 of 3204) and is more typical. These rank positions signal the provider is a major national entrant for faricimab-related billing and an above-average injector for intravitreal procedures, while participation in aflibercept use is solid but less exceptional.

The practice shows unusually high utilization of certain diagnostic and visit codes, pointing to high throughput of follow-up care: 92134 has 4K claims, $111K revenue and ranks #136 of 26868 providers (99th percentile; extreme outlier), and 99213 has 1.7K claims, $104.7K revenue and ranks #1499 of 457151 providers (100th percentile; extreme outlier). These volumes imply a clinic workflow oriented around frequent imaging and brief established-patient visits to support recurrent injection visits.

There is also concentrated billing of unclassified biologics: J3590 appears with 1.4K claims, $97.2K revenue and ranks #5 of 631 providers (99th percentile; extreme outlier). This suggests significant use of biologic products billed outside a single specific J-code pathway, which is material enough to affect revenue mix and claims review.

The provider performs some higher-complexity new-patient evaluations and occasional surgical procedures: 99204 appears with 220 claims and $25.3K revenue and ranks in the 98th percentile, and 67041 (vitrectomy) appears with 14 claims and $12K revenue. While surgical volume is limited in absolute terms, the presence of these codes alongside the high injection and imaging volumes indicates capability to manage more complex retinal cases and to triage surgical referrals in-house when needed.

The NPI has been enumerated since 2006-03-27 (~20 years ago), indicating a long-tenured practice. That longevity, combined with the concentration in retina therapeutics and extreme-percentile rankings on multiple codes, supports the interpretation of an established retina-focused practice with sustained referral and treatment volume.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

14 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J2777	Injection, faricimab‑svoa, 0.1 mg	64,260	$30	$1.9M
J0178	Injection, aflibercept, 1 mg	1,770	$690	$1.2M
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	2,900	$90	$255K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	3,970	$30	$111K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	1,690	$60	$104.7K
J3590	Unclassified biologics	1,410	$70	$97.2K
J2778	Injection, ranibizumab, 0.1 mg	420	$180	$76.4K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	220	$120	$25.3K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	280	$90	$24.7K
67041	In this procedure, the provider removes scar tissue from the retinal membrane that obscures vision. He removes vitreous humor, the gelatinous material that gives shape to the eye, using a mechanical…	10	$850	$12K

Showing 1–10 of 14

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 14 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Iowa Distribution

Todd Heilskov — 4 of 14 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Iowa

Full comparison — all codes billed, vs. state median

14 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J2777	9	20	43,140	$30	$1.7M
J0178	8	40	640	$690	$760.2K
J2778	16	20	780	$180	$259.9K
67028	6	60	420	$80	$80.6K
J3590	1	30	140	$100	$26.7K
99214	1,079	4,690	100	$70	$14.4K
67041	1	10	10	$980	$11.7K
99213	6	4,740	100	$50	$8K
92134	5	450	80	$30	$6.8K
99215	1,064	1,220	30	$110	$6.4K

Showing 1–10 of 14

Related Providers

Other providers that share a Tax Identification Number (TIN) with Todd Heilskov, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
James Singer	IA	Retina Specialist (Ophthalmology) Physician	$4.1M	$0
Christopher Haupert	IA	Retina Specialist (Ophthalmology) Physician	$3.9M	$0
Sushant Wagley	IA	Retina Specialist (Ophthalmology) Physician	$1.8M	$0

Nearby Providers

Other providers in the same ZIP code as Todd Heilskov, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Iowa Physicians Clinic Medical Foundation	IA	General Practice Physician	$0	$102.7M
Link Associates	IA	Intellectual and/or Developmental Disabilities Community Based Residential Treatment Facility	$0	$83.3M
Iowa Family Services, Inc	IA	Community/Behavioral Health Agency	$0	$9.9M
Revell-warrington Dental PC	IA	Pediatric Dentistry	$0	$9.2M
Csa	IA	Community/Behavioral Health Agency	$0	$8.8M
Kyle Alliman	IA	Ophthalmology Physician	$8.7M	$0
City Of West Des Moines	IA	Land Ambulance	$726.2K	$5.1M
Austin Strohbehn	IA	Retina Specialist (Ophthalmology) Physician	$5.8M	$0
Wolfe Surgery Center, LLC	IA	Ambulatory Surgical Clinic/Center	$4.1M	$1.3M
Iowa Home Care, LLC	IA	Home Health Agency	$0	$5.4M

Todd Heilskov — Billing Profile & Reimbursement Data

Sign up for Todd Heilskov — Billing Profile & Reimbursement Data policy alerts

Todd Heilskov — Billing Profile & Reimbursement Data

Sign up for Todd Heilskov — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References